On Thursday, Abbott Laboratories (ABT) stock saw a decline, ending the day at $115.03 which represents a decrease of $-0.71 or -0.61% from the prior close of $115.74. The stock opened at $115.98 and ...
As previously reported, Wolfe Research analyst Doug Schenkel initiated coverage of Grail (GRAL) with a Peer Perform rating and no price target ...
Wolfe Research initiated coverage of Bristol Myers (BMY) with a Peer Perform rating. The firm said there maybe a comeback story with Bristol, ...